JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, C.
Right arrow Articles by Reith, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, C.
Right arrow Articles by Reith, M. E.

Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?

C Xu and ME Reith

Department of Biology (C.X.), Illinois State University, Normal, USA.

Cocaine and its phenyltropane analogs, including 2beta-carbomethoxy- 3beta-(4-fluorophenyl) tropane can exist in either the cationic or the neutral form, with the proportion of each form determined by the pKA and ambient pH. It is unknown which form is the active form for binding to the dopamine transporter. Our study examines the following models for the pH dependency of [3H]2beta-carbomethoxy-3beta-(4-fluorophenyl) tropane binding to the dopamine transporter in rat striatal membranes: 1) pH does not affect the binding affinity of the ligand for the dopamine transporter, and the observed binding is a function only of the concentration of the active form; and 2) pH affects the binding affinity of the ligand for the transporter, and changes in this affinity as well as in the concentration of the active form of the ligand in the medium contribute to the observed binding changes upon varying pH. For each model, predictions are formulated for the case that either the cation, neutral base, or both are the active form, and these predictions are compared with the experimental data obtained over a pH range of 6 to 9.5. Observations for 2beta-carbomethoxy-3beta-(4- fluorophenyl) tropane, which can be both in the cationic and neutral form, are compared with those for cocaine methiodide, which is permanently cationic, and benzocaine, which is permanently neutral. Consonant with all data is a simple model in which the cationic and neutral form have similar binding activity and binding changes as a function of pH are caused by changes at the level of the transporter rather than the ligand.

Volume 278, Issue 3, pp. 1340-1348, 09/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. M. Francis, E. Y. Cheng, G. A. Weiland, and R. E. Oswald
Specific Activation of the alpha 7 Nicotinic Acetylcholine Receptor by a Quaternary Analog of Cocaine
Mol. Pharmacol., July 1, 2001; 60(1): 71 - 79.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
S. L. Ingram and S. G. Amara
Arachidonic Acid Stimulates a Novel Cocaine-Sensitive Cation Conductance Associated with the Human Dopamine Transporter
J. Neurosci., January 15, 2000; 20(2): 550 - 557.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Berfield, L. C. Wang, and M. E. A. Reith
Which Form of Dopamine Is the Substrate for the Human Dopamine Transporter: the Cationic or the Uncharged Species?
J. Biol. Chem., February 19, 1999; 274(8): 4876 - 4882.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Xu and M. E. A. Reith
WIN 35,428 and Mazindol Are Mutually Exclusive in Binding to the Cloned Human Dopamine Transporter
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 920 - 927.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.